Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singapore Paincare HoldingsSGX:FRQ 3-Year ROIIC % is -22.63 as of Jun. 2025. The stock has 5 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Singapore Paincare Holdings ranks worse than 77.71% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Singapore Paincare Holdings's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was -22.63%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Singapore Paincare Holdings's 3-Year ROIIC % or its related term are showing as below:
SGX:FRQ's 3-Year ROIIC % is ranked worse than 77.71% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.66
vs SGX:FRQ: -22.63
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Singapore Paincare Holdings 3-Year ROIIC % Related Terms
Singapore Paincare Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:FRQ vs HCA, THC, EHC: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Singapore Paincare Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singapore Paincare Holdings 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Singapore Paincare Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Singapore Paincare Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 4.424 (Jun. 2025) - 6.2893765 (Jun. 2022) )
/
( 29.955 (Jun. 2025) - 21.713 (Jun. 2022) )
=
-1.8653765
/
8.242
=
-22.63%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Singapore Paincare Holdings (SGX:FRQ) has a 3-Year ROIIC % of -22.63 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Singapore Paincare Holdings and its competitors. According to the industry distribution chart, Singapore Paincare Holdings ranks #481 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 77.7%.
Is Singapore Paincare Holdings' 3-Year ROIIC % too high?
Singapore Paincare Holdings' current 3-Year ROIIC % is -22.63. Based on the distribution chart, Singapore Paincare Holdings ranks #481 out of 619 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Paincare Holdings' 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Paincare Holdings ranks #481 out of 619 companies for 3-Year ROIIC %. This places Singapore Paincare Holdings in the lower half of its industry. The industry median 3-Year ROIIC % is 3.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.66, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Singapore Paincare Holdings and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Paincare Holdings's current 3-Year ROIIC % is -22.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Paincare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Singapore Paincare Holdings (SGX:FRQ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.17, compared to a current price of S$0.06 — trading 64.7% below its estimated fair value. The current 3-Year ROIIC % is -22.63. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Singapore Paincare Holdings (SGX:FRQ), the current 3-Year ROIIC % is -22.63 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, primary care, and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company operates mainly in Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:FRQ has been successfully added to your 
